<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-id>
      <journal-id journal-id-type="publisher-id">.</journal-id>
      <journal-title>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</journal-title><issn pub-type="ppub">2621-4814</issn><issn pub-type="epub">2621-4814</issn><publisher>
      	<publisher-name>Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.33084/bjop.v5i1.2708</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Research Article</subject>
        </subj-group>
        <subj-group><subject>Nanocosmetics</subject><subject>Determination of the concentration</subject><subject>Acousto-magnetic method</subject></subj-group>
      </article-categories>
      <title-group>
        <article-title>Control of the Nanoparticles Content in Cosmetic Medicines</article-title><subtitle>Control of the Nanoparticles Content in Cosmetic Medicines</subtitle></title-group>
      <contrib-group><contrib contrib-type="author">
	<name name-style="western">
	<surname>Rakhimova</surname>
		<given-names>Marina Viktorivna</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Bondarenko</surname>
		<given-names>Igor Nikolaevich</given-names>
	</name>
	<aff>Department of Biomedical Engineering, Kharkiv National University of Radio Electronics, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Avrunin</surname>
		<given-names>Oleg Grigorovitsh</given-names>
	</name>
	<aff>Department of Biomedical Engineering, Kharkiv National University of Radio Electronics, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Fedosov</surname>
		<given-names>Andrii I.</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Sych</surname>
		<given-names>Irina A.</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Yaremenko</surname>
		<given-names>Vitaliy Dmitrievich</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Vislous</surname>
		<given-names>Olha O.</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib><contrib contrib-type="author">
	<name name-style="western">
	<surname>Perekhoda</surname>
		<given-names>Lina O.</given-names>
	</name>
	<aff>Department of Pharmacy, National University of Pharmacy, Kharkiv, Kharkiv Oblast, Ukraine</aff>
	</contrib></contrib-group>		
      <pub-date pub-type="ppub">
        <month>02</month>
        <year>2022</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>28</day>
        <month>02</month>
        <year>2022</year>
      </pub-date>
      <volume>5</volume>
      <issue>1</issue>
      <permissions>
        <copyright-statement>© 2022 Marina Viktorivna Rakhimova, Igor Nikolaevich Bondarenko, Oleg Grigorovitsh Avrunin, Andrii I. Fedosov, Irina A. Sych, Vitaliy Dmitrievich Yaremenko, Olha O. Vislous, Lina O. Perekhoda</copyright-statement>
        <copyright-year>2022</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-sa/4.0/"><p>This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.</p></license>
      </permissions>
      <related-article related-article-type="companion" vol="2" page="e235" id="RA1" ext-link-type="pmc">
			<article-title>Control of the Nanoparticles Content in Cosmetic Medicines</article-title>
      </related-article>
	  <abstract abstract-type="toc">
		<p>
			The safety of nanoparticles used in medical cosmetology and dermatology raises significant concerns. One of the tasks of analyzing the concentration of nanoparticles that must be solved for the practical analysis of the quality of products with nanoparticles is the quantitative analysis of the content of nanoparticles. The previously developed acousto-magnetic method (AMM) for determining the concentration of APIs as magnetic nanoparticles can be used to determine the nanoparticles' concentration when samples are prepared as a colloidal solution. It is shown that the described method not only can be applied for quality control in cosmetology and dermatology but also can be simplified by using a less sensitive magnetometer, which makes this direct method more available in the entire range of values ​​of the concentration of magnetic nanoparticles used in medical cosmetology and dermatology.
		</p>
		</abstract>
    </article-meta>
  </front>
  <body><sec>
			<title>INTRODUCTION</title>
				<p >The currently
observed increased interest in metal nanoparticles (NPs) is caused by discovering
their unique physical and chemical properties features of biological action,
which often differ from the properties of this substance in a macrodispersed
form. Good prospects are for metal NPs in medicine, particularly dermatology. A
new direction of developing nano preparation is forming a complex between known
drugs and NPs, which gives the possibility of a deeper penetration of such
complex drugs into the pathological process. To maximize the benefits of
nanoscale materials, accurate control of their concentration is a necessary
condition. In particular, this is necessary regarding magnetic drug targeting
to maximize the efficacy and minimize the toxicity of the nanomaterials.
Towards this significant yet chronic problem, various strategies are currently
under development<bold>1</bold>.</p><p >Some of the
concentration determination methods apply to the ensemble of physical
properties of dispersions of NPs (for example, light absorption), while others,
such as microscopy and sensors, directly count individual particles. The UV-Vis spectroscopy<bold>2</bold>, turbidimetry<bold>3</bold>, and dynamic light scattering (DLS)<bold>4</bold> are three optical methods that measure the intensity of light upon
absorption or scattering by nanoparticles. The turbidimetry method measures a
decrease in the intensity of the incident light caused by light scattering of
nanoparticle suspensions. The values measured by these methods are ensemble
properties of nanoparticle suspensions, which can reflect averaged
concentrations with statistical significance. The limitations of these three
methods lie in the complexity of measuring extinction/scattering coefficient or
employing a reference sample with a known concentration.</p><p >Laser-induced
breakdown detection (LIBD) is another method measuring the plasma generation
from nanoparticles irradiated by an intense, focused laser in a suspension. It
has a wide application in various particles of different sizes, but a special
laser system is required to ensure the breakdown of nanoparticles. Unlike
measuring ensemble quantities of nanoparticle dispersions, several techniques
enable counting individual nanoparticles under direct visualization<bold>5</bold>.</p><p >Resistive-pulsed
sensing, inductively coupled plasma mass spectrometry (ICPMS), and light
scattering particle counter are three methods that can count particles. They
provide concentration information based on the signal pulses from a sensor, and
a standard reference sample is usually required for calibration. The ICPMS is a highly sensitive and rapid analytical technique for elemental
analysis at ultra-low concentrations. The samples in traditional ICPMS are
usually metal ions dissolved in solution, and the concentration of total metal
can be calculated based on the averaged intensity of the ion peak over a
measuring period<bold>6</bold>.</p><p >Mössbauer spectroscopy
is widely used to determine magnetic NPs (MNPs). The methods
based on the analysis of X-ray diffraction data have a reasonably wide range of
determined parameters (phase composition, structure, average size, and
morphological characteristics of nanocrystals. However, using this method can
lead to significant errors due to the influence of various factors on the
effect of broadening of diffraction maxima and others. When the Mössbauer spectroscopy
method is used for measurements at 4.2 K, the nanoparticles typically exhibit
well-defined but complicated hyperfine spectra that may present some evaluation
problems but eventually yield reliable results. The different situation was
when nanoparticles of Fe3O4 (magnetite) and gamma-Fe2O3
(maghemite) had been studied by Mössbauer spectroscopy at room temperature when
they are superparamagnetic. The magnetic hyperfine fields were averaged to
zero, making Mössbauer spectroscopy useless for the characterization of
superparamagnetic NPs<bold>7</bold>. </p><p >Among the
magnetic NPs suitable for use in medicine, particles of iron oxide Fe3O4
can be distinguished due to their biological compatibility with biological
objects. These particles are superparamagnetic and cannot be studied by the Mössbauer
spectroscopy method at room temperature. The characterization of magnetic iron
oxide NPs is important for their use as contrast agents in magnetic resonance
imaging, as carriers for magnetic drug targeting, for local hyperthermia.
Magnetic resonance imaging (MRI) can be used for magnetic particles
concentration determination<bold>8</bold>.</p><p >Magnetic
nanoparticles change the electromagnetic excitation spectra of organic
molecules of the human body. Registration of these spectra by MRI provides information
on the distribution of particles in space and, consequently, the concentration
of drugs coupled with them. The special features of the MRI method are the high
cost and the associated with it less availability and give information about
NPs distribution. Analysis of existing methods shows no universal method for
determining the concentration of NPs of various types<bold>9</bold>. Each of the listed methods has both certain advantages over others and
limitations. In particular, developing a more straightforward method applicable
to in vivo and in vitro use for superparamagnetic nanostructures
at room temperature is important. This study aims to describes a
simplified acoustomagnetic method (AMM) of detecting magnetic particles
concentration<bold>10</bold> and experimental procedure for determining the concentration of MNPs in a
colloidal solution that is the model of the cosmetic products with MNPs both in
vivo and in vitro that is important in dermatology as the
possibility of penetration through the skin, in particular through the
sebaceous glands and hair follicles. Such carriers provide long-term drug
release and protect it from degradation.</p>
			</sec><sec>
			<title>MATERIALS AND METHODS</title>
				<p ><bold>Materials</bold></p><p >The
object of study was a colloidal solution of nanoparticles based on Fe3O4
in a mixture of oleic acid and kerosene, a model sample of a cosmetic product
colloidal solution. The average particle size with magnetite was 50-150 nm,
size of Fe3O4 was much less. Oleic acid prevents powder
particles from sticking together in solution, and kerosene provides the
necessary viscosity. For biophysical applications, it is recommended to use a
solution with a concentration of nanoparticles not more than 5%. In our
experiments, the weight concentration of the actual magnetite was no more than
0.15%. The viscosity of the suspension was chosen close to the viscosity of the
blood (5 x 10-3 poise).</p><p ><bold>Methods</bold></p><p >The experimental
verification of the applicability of the AMM method was carried out using the
setup shown in <bold>Figure 1</bold>. The scheme consists of three
component blocks (<bold>A</bold>, <bold>B</bold>, and <bold>C</bold>), allowing to determine the
concentration of nanoparticles in a vessel with a studied medium. Block <bold>A</bold>
is a conditional image of a plot of a model studied medium with nanoparticles
affected by a constant magnetic field Hd and ultrasonic
radiation (<bold>US</bold>). The result of these actions is the generation under the
action of US on magnetic particles of an alternating magnetic field Ha,
depending on the concentration of the nanoparticles in the indicated studied
medium. Block <bold>B</bold> is a sensitive device for measuring the field Ha.
Block <bold>C</bold> is a recorder of the value Ha. Ultrasonic
radiation has induced excitation of vibrations of magnetic nanoparticles in the
target area of ​​the
sample, located in the external uniform constant magnetic field Hd.
Oscillations of the particle ensemble oriented (polarized) by Hd
field caused the appearance in the surrounding space of the alternating
magnetic field Ha with a frequency of <bold>US</bold>. The magnetic
flux of this field depends on the concentration of nanoparticles in the studied
region and can be measured by a sensitive detector located outside this region.
As such a detector, it can be used a superconducting quantum magnetometer,
which, as is known, has the highest sensitivity and dynamic measurement range
among the known types of magnetometers<bold>11</bold>. In the experiments
with a model of a cosmetic product due to the higher permissible content of
magnetite nanoparticles, which themselves do not belong to highly toxic
additives, a highly sensitive voltmeter was used. In addition, in practice, the
possibility to use a sensor with a lower sensitivity compared to the
superconducting quantum magnetometer will make the AMM technique available for
practical use in the future.</p><p ><bold>Figure</bold><bold>1</bold><bold>.</bold> Block diagram of a measuring
system</p>
			</sec><sec>
			<title>RESULTS AND DISCUSSION</title>
				<p >Voltage (<bold>U</bold><bold>)</bold> on the induction coil of unit <bold>B</bold>
resulted from the excitation of oscillations of magnetic nanoparticles in the
target area of ​​the medium under the action of ultrasonic radiation.
Accordingly to the Faraday’s law on electromagnetic induction, the
resulting <bold>U</bold> should be proportional to the magnitude of the
nanoparticles' total magnetic field at the detector's location and their speed
relative to the detector<bold>12</bold>. In turn, field Ha and
<bold>U</bold> are proportional to the concentration (<bold>K</bold><bold>)</bold> of the nanoparticles in the moving
solution. In the specific case of the described experimental installation, the
solution with the nanoparticles was moved using an ultrasonic wave, and the
magnetic moments of the nanoparticles were oriented along the required
direction by constant magnetic field Hd. In this case, the
speed of movement of the nanoparticles is proportional to the power of the
ultrasound. The magnitude of the <bold>U</bold> is proportional to the concentration
of nanoparticles in the field of action of <bold>US</bold> and magnetic field Hd
and the <bold>US</bold> intensity (<bold>I</bold><bold>)</bold>. Dependence of the <bold>U</bold> at the induction coil on the <bold>I</bold> of
ultrasound can be described by the <bold>Equation
[1]</bold>: </p><p >
 
 
  
  
  
  
  
  
  
  
  
  
  
  
 
 
 

 
<bold>[1]</bold></p><p >In which the parameter <bold>k</bold> characterizes the magnetic field
properties in the coil area, the <bold>N</bold> number of the magnetic nanoparticles
creates a magnetic field when all nanoparticles are oriented in the direction
perpendicular to the plane of the coil by uniform constant magnetic field Hd.
The value of <bold>K</bold> of the magnetic nanoparticles is equal to as described in
<bold>Equation [2]</bold>:</p><p >
 
<bold>[2]</bold></p><p >In which <bold>V</bold>, <bold>ρ</bold>,
and <bold>m</bold> are the volume of one nanoparticle, its specific weight, and the total mass of
the solution, respectively. The increase of the voltage on the induction coil
proportionally to the <bold>I</bold> of the ultrasound confirmed the possibility of
the magnetic particles registration using an acoustomagnetic method to measure
the quantitative value of the concentration of the magnetic particles (<bold>Figure 2</bold>).</p><p ></p><p ><bold>Figure</bold><bold>2</bold><bold>.</bold> Dependence of the effective
value of the alternating voltage U on the US intensity I</p>
			</sec><sec>
			<title>CONCLUSION</title>
				<p >It
is proposed to use a simplified method for determining the concentration of the
cosmetic preparations when superconducting magnetometer usage is replaced by
the highly sensitive voltmeter, which makes it possible to exclude the use of
cryogenic liquid and makes the proposed method more accessible in practice for
quality control of cosmetic preparations. Also, it has been experimentally
shown that the sensitivity of detecting the response of an ensemble of MNPs
using the selected measurement scheme is sufficient at the therapeutic dose
with nanoparticles, which may be contained in a cosmetic product. The chosen
method has several advantages over Mössbauer spectroscopy since it allows the
concentration of superparamagnetic MNPs to be measured at room temperature, as Mössbauer
spectroscopy is useless at this condition. Compared to MRI, the chosen
technique is a direct method for determining the magnetic field's concentration
and magnitude is significantly lower than it is used for MRI. Unlike most
techniques, the chosen method allows its use not only for in vitro
measurements but also for in vivo measurements at the penetration of
MNPs through the skin in dermatology.</p>
			</sec><sec>
			<title>ACKNOWLEDGMENT</title>
				<p >None.</p>
			</sec><sec>
			<title>AUTHORS’ CONTRIBUTION</title>
				<p >All authors have an
equal contribution in carrying out this study.</p>
			</sec><sec>
			<title>DATA AVAILABILITY</title>
				<p >None.</p>
			</sec><sec>
			<title>CONFLICT OF INTEREST</title>
				<p >The
authors have declared no conflict of interest.</p>
			</sec><sec>
			<title>REFERENCES</title>
				<p >1. Sukhanova A, Bozrova S, Sokolov P, Berestovoy M,
Karaulov A, Nabiev I. Dependence of Nanoparticle Toxicity on Their Physical and
Chemical Properties. Nanoscale Res Lett. 2018;13(1):44. doi:10.1186/s11671-018-2457-x</p><p >2. Jain PK, Lee KS, El-Sayed IH, El-Sayed MA.
Calculated absorption and scattering properties of gold nanoparticles of
different size, shape, and composition: applications in biological imaging and
biomedicine. J Phys Chem B. 2006;110(14):7238-48. doi:10.1021/jp057170o</p><p >3. Khlebtsov BN, Khanadeev VA, Khlebtsov NG.
Determination of the Size, Concentration, and Refractive Index of Silica
Nanoparticles from Turbidity Spectra. Langmuir. 2008;24(16):8964-70. doi:10.1021/la8010053</p><p >4. Liu X, Dai Q, Austin L, Coutts J, Knowles G, Zou
J, et al. A one-step homogeneous immunoassay for cancer biomarker detection
using gold nanoparticle probes coupled with dynamic light scattering. J Am Chem
Soc. 2018;130(9):2780-2. doi:10.1021/ja711298b</p><p >5. De Giacomo A, Koral C, Valenza G, Gaudiuso R,
Dell’Aglio M. Nanoparticle Enhanced Laser-Induced Breakdown Spectroscopy for Microdrop
Analysis at subppm Level. Anal Chem. 2016;88(10):5251-7. doi:10.1021/acs.analchem.6b00324</p><p >6. Zhang R, Zhao H. Small-Angle Particle Counting
Coupled Photometry for Real-Time Detection of Respirable Particle Size
Segmentation Mass Concentration. Sensors. 2021;21(17):5977. doi:10.3390/s21175977</p><p >7. Mourdikoudis S, Pallares RM, Thanh NTK. Characterization
techniques for nanoparticles: comparison and complementarity upon studying
nanoparticle properties. Nanoscale. 2018;10:12871-934. doi:10.1039/C8NR02278J</p><p >8. Hurley KR, Ring HL, Kang H, Klein ND, Haynes CL.
Characterization of Magnetic Nanoparticles in Biological Matrices. Anal Chem.
2015;87(23):11611-9. doi:10.1021/acs.analchem.5b02229</p><p >9. Khan I, Saeed K, Khan I. Nanoparticles:
Properties, applications and toxicities. Arab J Chem. 2019;12(7):908-31. doi:10.1016/j.arabjc.2017.05.011</p><p >10. Bondarenko SI, Avrunin OG, Bondarenko IS,
Krevsun AV, Koverya VP, Rakhimova MV. On the measurements of magnetic
nanoparticle concentration in a biological medium using a superconducting
quantum magnetometer. Low Temp Phys. 2020;46:1094. doi:10.1063/10.0002152 </p><p >11. Avrunin OG, Bondarenko IS, Bondarenko SI,
Semenets VV, inventors; Kharkiv National University of Radio Electronics,
assignee. Method for the remote recognition of the manifestation of magnetic
nanoparticles in a biological environment. Ukraine patent 137159. 2019 Oct 10
[cited 2021 Sep 10]. 19 p.</p><p >12. Smith RT, Jjunju FPM, Young IS, Taylor S, Maher
S. A physical model for low-frequency electromagnetic induction in the near
field based on direct interaction between transmitter and receiver electrons.
Proc Math Phys Eng Sci. 2016;472(2191):20160338. doi:10.1098/rspa.2016.0338</p>
			</sec></body>
  <back>
    <ack>
      <p>None.</p>
    </ack>
  </back>
</article>